Bernard Roizman

This inventor holds 39 USPTO granted patents and 7 published patent applications and 2 EPO patents, primarily in Oncolytic Virus Therapy. Top assignees: Arch Development Corporation, The University of Chicago, The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 1985-2020.

USPTO Granted Patents = 39 (Patent Applications = 7)

% Patents Active = 84.6

EPO Patents = 2

Average Co-Inventor Count = 1.7

ph-index = 13

Forward Citations = 530(Granted Patents)

Company Filing History:

24 out of 349

Arch Development Corporation

patents

10 out of 962

The University of Chicago

patents

2 out of 641

The UAB Research Foundation (The University of Alabama at Birmingham)

University Patents, Inc.

patents

where one patent can have more than one assignee

Years Active: 1985-2020

Loading Chart...

Areas of Expertise:

Oncolytic Virus

Herpes Simplex Virus

Tumor Treatment

Genetically Engineered

Cancer Therapy

Vaccine Development

Virus Targeting

Apoptosis Inhibition

Viral Vector

HSV-2 Infections

Recombinant Viruses

Immunization Methods

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10561708 - Anti-tumor therapy (2020-02-18),

2. 9803006 - Targeting of herpes simplex virus to specific receptors (2017-10-31),

3. 9790504 - Anti-tumor therapy (2017-10-17),

4. 9669036 - Modulation of reactivation of a latent virus (2017-06-06),

5. 8927251 - Targeting of herpes simplex virus to specific receptors (2015-01-06),

6. 8772261 - Treatment of tumors with genetically engineered herpes virus (2014-07-08),

7. 8318691 - Treatment of tumors with genetically engineered herpes virus (2012-11-27),

8. 7892740 - Prognosis and therapy predictive markers and methods of use (2011-02-22),

9. 7744899 - Recombinant herpes simplex virus useful for treating neoplastic disease (2010-06-29),

10. 7592169 - Methods and compositions for treatment and prevention of HSV-2 infections and conditions (2009-09-22),

11. 7550148 - Targeting of Herpes simplex virus to specific receptors (2009-06-23),

12. 7501126 - Targeting of herpes simplex virus to specific receptors (2009-03-10),

13. 6846670 - Genetically engineered herpes virus for the treatment of cardiovascular disease (2005-01-25),

14. 6723511 - Herpes simplex virus ICP4 is an inhibitor of apoptosis (2004-04-20),

15. 6410704 - Methods and compositions for the preparation and use of a herpes protease (2002-06-25),

Title: The Legacy of Bernard Roizman, Inventor from Chicago

Introduction: Bernard Roizman, a distinguished inventor hailing from the vibrant city of Chicago, Illinois, has made significant contributions to the field of innovation through his groundbreaking work in various patents and inventions.

Latest Patents: Roizman's latest patents showcase his ongoing commitment to pushing the boundaries of technology and science, with a focus on advancements in the medical and biotechnological sectors.

Career Highlights: Throughout his illustrious career, Roizman has been recognized for his pioneering spirit and inventive prowess, earning multiple accolades for his transformative inventions that have revolutionized the industry.

Collaborations: Roizman's collaborative efforts with leading research institutions, universities, and companies have been instrumental in bringing his visionary ideas to life, fostering a culture of innovation and progress in the field.

Conclusion: Bernard Roizman's remarkable journey as an inventor exemplifies the power of creativity, dedication, and ingenuity in shaping the future of technology and driving positive change in society.